Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer

被引:6
|
作者
Fraser, Allison [1 ,2 ]
Odelli, Cathy [1 ,2 ]
Britton, Ben [2 ,3 ]
Kumar, Mahesh [1 ,2 ]
Day, Fiona [1 ,2 ]
Tieu, Minh Thi [1 ,2 ]
Wratten, Chris [1 ,2 ]
机构
[1] Calvary Mater Newcastle, Locked Mail Bag 7,Hunter Reg Mail Ctr, Waratah, NSW, Australia
[2] Univ Newcastle, Callaghan, NSW, Australia
[3] John Hunter Hosp, Hunter Reg Mail Ctr, New Lambton Hts, NSW, Australia
关键词
chemoradiotherapy; enteral nutrition; gastrostomy; head and neck cancer; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PROGNOSTIC-FACTORS; TUBE; RADIOTHERAPY; GUIDELINES; NUTRITION; RADIATION; PEG; CHEMOTHERAPY; PLACEMENT;
D O I
10.1111/ajco.13342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim The routine use of prophylactic percutaneous endoscopic gastrostomy (PEG) tubes for nutrition support during radical chemoradiation for head and neck cancer has been suggested to result in PEG dependency. This research aimed to determine the rates of gastrostomy dependency at the Calvary Mater Newcastle (CMN) where PEGs are routinely used and to identify potentially modifiable risk factors. Methods All patients with head and neck cancer planned for curative chemoradiation with a prophylactic PEG inserted were included in this review. Medical records of 250 patients treated between 2000 and 2015 were examined. Results Overall, eight patients (3%) were unable to wean. At 12 months following treatment, 16 patients (6%) still required PEG tubes for feeding. A greater T extent (T4 or synchronous head and neck tumors) and number of days Nil By Mouth (NBM) remained as significant independent risk factors for PEG dependency at 12 months (Textent OR 6.96 P P = .004) and overall (Textent OR8.04 P = .02; NBM OR1.01 P = .001). Associations with NBM were investigated, which demonstrated that patients had less NBM days with intensity-modulated radiation therapy (IMRT) (beta-13.3, P = .007) and seeing a speech pathologist during treatment (beta-11.9, P = .026). More NBM days were associated with tumors with greater T extent (beta+22; P < .001). Conclusion The routine use of prophylactic PEGs has not resulted in significant rates of PEG dependency at the CMN. Seeing a speech pathologist during treatment and IMRT may decrease time NBM, which was identified as a potentially modifiable risk factor for PEG dependency.
引用
收藏
页码:E198 / E206
页数:9
相关论文
共 18 条
  • [1] PROPHYLACTIC PERCUTANEOUS GASTROSTOMY TUBE FOR HEAD AND NECK CANCER PATIENTS UNDERGOING CHEMORADIATION TREATMENT
    Contreras Martinez, J.
    Perez, G.
    Lazo, A.
    Herruzo, I.
    Gonzalo, M.
    Lainez, L.
    Olveira, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S328 - S328
  • [2] Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation
    Nguyen, Nam P.
    North, Debra
    Smith, Herbert J.
    Dutta, Suresh
    Alfieri, Alan
    Karlsson, Ulf
    Lee, Howard
    Martinez, Tomas
    Lemanski, Claire
    Nguyen, Ly M.
    Ludin, Adir
    Sallah, Sabah
    [J]. SURGICAL ONCOLOGY-OXFORD, 2006, 15 (04): : 199 - 203
  • [3] Prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients: results of tertiary institute
    Jaakko Pulkkinen
    Jami Rekola
    Mari Asanti
    Reidar Grénman
    [J]. European Archives of Oto-Rhino-Laryngology, 2014, 271 : 1755 - 1758
  • [4] USE OF PROPHYLACTIC GASTROSTOMY TUBE BEFORE CHEMORADIATION IN LOCALLY ADVANCED HEAD AND NECK CANCER PATIENTS
    Masood, A.
    Mehmood, T.
    Iqbal, H.
    Ali, M.
    Hussain, R.
    Jamshed, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S14 - S14
  • [5] Prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients: results of tertiary institute
    Pulkkinen, Jaakko
    Rekola, Jami
    Asanti, Mari
    Grenman, Reidar
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (06) : 1755 - 1758
  • [6] Percutaneous endoscopic gastrostomy tube dependence following chemoradiation in head and neck cancer patients
    Pohar, Surjeet
    Demarcantonio, Michael
    Whiting, Phillip
    Crandley, Edwin
    Wadsworth, John
    Karakla, Daniel
    [J]. LARYNGOSCOPE, 2015, 125 (06): : 1366 - 1371
  • [7] Prophylactic gastrostomy tube insertion prior to treatment of head and neck cancer: clinical outcomes from a single tertiary centre
    Kiely, C. J.
    Benhamu, J.
    Eade, T. N.
    Pattullo, V.
    Stiel, D.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 37 - 38
  • [8] Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort
    Dechaphunkul, Tanadech
    Soonthornrak, Pawitra
    Geater, Sarayut Lucien
    Dechaphunkul, Arunee
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (04)
  • [9] PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBES; A RETROSPECTIVE ANALYSIS IN PATIENTS WITH HEAD AND NECK CANCER OVER 5 YEARS
    Mc Auliffe, E.
    Murphy, C.
    Clifford, E.
    Perrott, L.
    Heavers, A.
    O'Hanlon, D.
    [J]. GUT, 2017, 66 : A10 - A11
  • [10] Prophylactic Endoscopic Gastrostomy in Patients With Head and Neck Cancer: A Canadian Experience in an Academic Oncology Center From 2003-2019
    Ghaith, Jenan
    Cohen, Lawrence
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S660 - S660